Preferred Label : Orphan Drug;
NCIt definition : A compound or product that demonstrates promise for the diagnosis and/or treatment
of rare diseases and conditions that affect fewer than 200,000 people. The U.S. Orphan
Drug Act (1983) encourages development of these therapeutics by tax breaks and a seven-year
monopoly on drug sales. These incentives promote the development and manufacturing
of such therapeutics, which otherwise might not be profitable because of the small
potential market.;
Origin ID : C48201;
UMLS CUI : C0013232;
Currated CISMeF NLP mapping
- Semantic type(s)
- UMLS correspondences (same concept)
